West University Place, TX Ketamine Therapy Clinic: Sophisticated Treatment for Depression, Anxiety, PTSD, and Chronic Pain That Respond to Neither Medication Nor Willpower Alone

West U residents tend to approach problems the way they approach everything — with research, rigor, and follow-through. If you’re reading this page, you’ve likely already done exactly that with your mental health treatment. You’ve studied the medications. You’ve asked the right questions. You may have consulted multiple psychiatrists, tried therapy modalities with genuine commitment, and given each medication the full trial duration before concluding it wasn’t working. That level of diligence deserves an honest explanation of why those treatments fell short — and it isn’t the explanation you might expect.

Every standard antidepressant — regardless of its specific drug name, brand, or class — operates within the same neurochemical territory: serotonin, norepinephrine, or dopamine. Switching from one to another is a change in approach within that territory, not a departure from it. For approximately one-third of patients, the answer doesn’t live there. The real disruption is structural — chronic illness physically thins the synaptic connections between neurons in brain regions responsible for mood regulation, emotional processing, and pain modulation. No drug designed to adjust neurotransmitter availability can repair that structural damage. Ketamine can. Working through the glutamate system, the brain’s most extensive communication network, ketamine triggers rapid rebuilding of the very connections chronic conditions have degraded. Psychology Today describes ketamine-assisted therapy as a treatment that works differently from traditional antidepressants, noting its ability to promote the growth of new neural connections and its particular effectiveness for individuals who haven’t found relief through other medications. Catalyst Health & Wellness delivers ketamine therapy through three Houston-area clinics — including the South Loop location just minutes from West U — each under the supervision of Dr. Ho, a board-certified anesthesiologist and former pediatrician whose combined training provides the pharmacological precision and compassionate patient care this treatment requires.

Ketamine’s medical résumé predates its psychiatric application by decades. Synthesized in 1962 and FDA-approved as a general anesthetic in 1970, it became essential to surgical suites, emergency departments, pediatric units, and battlefield medicine across the globe. Over fifty years of continuous high-volume use have produced a safety record few medications can rival.

The psychiatric dimension emerged from an observation nobody predicted. In the late 1990s, researchers studying glutamate — the neurotransmitter carrying the majority of excitatory brain signaling — discovered that sub-anesthetic ketamine doses produced something unprecedented: rapid, substantial depression relief in patients who’d failed every conventional option. The timeline was hours rather than weeks. The patients who benefited most were precisely those other drugs had left behind.

The science is now thorough. Standard antidepressants increase neurotransmitter concentration and rely on the brain’s slow adaptation over four to eight weeks. Ketamine skips that process entirely. It blocks NMDA receptors in the glutamate system, initiating a cascade that releases brain-derived neurotrophic factor (BDNF) — the protein that physically constructs new synaptic connections in regions governing mood, threat perception, and pain processing. Chronic conditions erode these connections over months and years. Ketamine restores them — frequently within a single treatment. This shared structural deficit across depression, anxiety, PTSD, OCD, chronic pain, and suicidal ideation explains why one mechanism simultaneously helps conditions that appear unrelated on the surface but share the same underlying neural substrate.